The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data

OBJECTIVES: To describe and compare the occurrence of newly diagnosed uveitis in children with JIA receiving MTX, etanercept, adalimumab and infliximab. METHODS: This on-drug analysis included patients within UK JIA registries (British Society for Paediatric and Adolescent Rheumatology Etanercept Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Rebecca, De Cock, Diederik, Kearsley-Fleet, Lianne, Southwood, Taunton, Baildam, Eileen, Beresford, Michael W, Foster, Helen E, Thomson, Wendy, Ramanan, Athimalaipet V, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244776/
https://www.ncbi.nlm.nih.gov/pubmed/31605484
http://dx.doi.org/10.1093/rheumatology/kez449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244776/
https://www.ncbi.nlm.nih.gov/pubmed/31605484
http://dx.doi.org/10.1093/rheumatology/kez449

Ejemplares similares